Skip to content

Company · founded 2011

Zalgen (United States)

Germantown, United States · zalgenlabs.com

Manage this page

Citations, last 5 years: 1 239
Works, last 5 years: 32
h-index: 50
Scientists listed: 4
Grants since 2016: 7

Grants received

2018–2023 · research · R01

Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies

Luis Manuel Branco · Zalgen (United States) · funded by National Institutes of Health

$1.5MViral Infections and Outbreaks Research

2018–2023 · research · R01

Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies

Luis Manuel Branco · Zalgen (United States) · funded by National Institutes of Health

$1.2MViral Infections and Outbreaks Research

2018–2023 · research · R01

Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies

Luis Manuel Branco · Zalgen (United States) · funded by National Institutes of Health

$1.2MViral Infections and Outbreaks Research

2018–2021 · research · R43

Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine

Matthew L Boisen · Zalgen (United States) · funded by National Institutes of Health

$299.1kViral Infections and Outbreaks Research

2018–2020 · research · R43

Glycoprotein Immunoassay to Measure Protective Response to Lassa Vaccine

Matthew L Boisen · Zalgen (United States) · funded by National Institutes of Health

$497.1kViral Infections and Outbreaks Research

2018–2023 · research · R01

Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies

Luis Manuel Branco · Zalgen (United States) · funded by National Institutes of Health

$1.2MViral Infections and Outbreaks Research

2018–2024 · research · R01

Structure-Guided Design of Broadly Neutralizing Lassa Virus BiSpecific Antibodies

Luis Manuel Branco · Zalgen (United States) · funded by National Institutes of Health

$1.2MViral Infections and Outbreaks Research